{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:16:45Z","timestamp":1792214205533,"version":"4.4.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00415-026-13703-6","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:11:55Z","timestamp":1771528315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A phenomenological approach to spastic movement disorders: an international expert panel consensus"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-1353","authenticated-orcid":false,"given":"Bo","family":"Biering-S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Wissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Reebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard E.","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ertzgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"10","key":"13703_CR1","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/dmcn.15582","volume":"65","author":"DE Lumsden","year":"2023","unstructured":"Lumsden DE (2023) Spastic dystonia: still a valid term. Dev Med Child Neurol 65(10):1308\u20131315","journal-title":"Dev Med Child Neurol"},{"key":"13703_CR2","unstructured":"E. Francisco G. Does spasticity need a new name? Keynote lecture. presented at: The 19th\u00a0congress of the international society of physical and rehabilitation medicine.; 2025; Marrakesh, Morocco"},{"issue":"1","key":"13703_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mds.30038","volume":"40","author":"J Gracies","year":"2025","unstructured":"Gracies J, Alter KE, Biering-S\u00f8rensen B, Dewald JPA, Dressler D, Esquenazi A et al (2025) Spastic paresis: a treatable movement disorder. Mov Disord 40(1):44\u201350","journal-title":"Mov Disord"},{"issue":"6","key":"13703_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.rehab.2018.10.004","volume":"62","author":"M Baude","year":"2019","unstructured":"Baude M, Nielsen JB, Gracies JM (2019) The neurophysiology of deforming spastic paresis: a revised taxonomy. Ann Phys Rehabil Med 62(6):426\u2013430","journal-title":"Ann Phys Rehabil Med"},{"key":"13703_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-78367-8","volume-title":"Spasticity [Internet]","author":"AF Thilmann","year":"1993","unstructured":"Thilmann AF (1993) Spasticity: history, definitions, and usage of the term. In: Thilmann AF, Burke DJ, Rymer WZ (eds) Spasticity [Internet]. Springer Berlin Heidelberg, Berlin Heidelberg"},{"issue":"12","key":"13703_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1212\/WNL.30.12.1303","volume":"30","author":"JW Lance","year":"1980","unstructured":"Lance JW (1980) The control of muscle tone, reflexes, and movement: Robert Wartenberg lecture. Neurology 30(12):1303\u20131313","journal-title":"Neurology"},{"issue":"1\u20132","key":"13703_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09638280400014576","volume":"27","author":"AD Pandyan","year":"2005","unstructured":"Pandyan AD, Gregoric M, Barnes MP, Wood D, Van Wijck F, Burridge J et al (2005) Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil 27(1\u20132):2\u20136","journal-title":"Disabil Rehabil"},{"issue":"4","key":"13703_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00415-018-8759-1","volume":"265","author":"D Dressler","year":"2018","unstructured":"Dressler D, Bhidayasiri R, Bohlega S, Chana P, Chien HF, Chung TM et al (2018) Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy. J Neurol 265(4):856\u2013862","journal-title":"J Neurol"},{"key":"13703_CR9","doi-asserted-by":"crossref","unstructured":"Albanese A, Bhatia KP, Fung VSC, Hallett M, Jankovic J, Klein C, et al. 2025 Definition and classification of dystonia. Mov Disord, mds.30220","DOI":"10.1002\/mds.30220"},{"issue":"7","key":"13703_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VSC et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord Off J Mov Disord Soc 28(7):863\u2013873","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"1","key":"13703_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED et al (2018) Consensus statement on the classification of tremors. From the task force on tremor of the international parkinson and movement disorder society. Mov Disord 33(1):75\u201387","journal-title":"Mov Disord"},{"issue":"10","key":"13703_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1212\/WNL.0000000000002440","volume":"86","author":"GB Raina","year":"2016","unstructured":"Raina GB, Cersosimo MG, Folgar SS, Giugni JC, Calandra C, Paviolo JP et al (2016) Holmes tremor: clinical description, lesion localization, and treatment in a series of 29 cases. Neurology 86(10):931\u2013938","journal-title":"Neurology"},{"key":"13703_CR13","unstructured":"Lui F, Merical B, S\u00e1nchez-Manso JC. Chorea. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430923\/. Accessed 9 Jul 2025"},{"key":"13703_CR14","unstructured":"Chorea & Huntington\u2019s Disease [Internet]. https:\/\/www.movementdisorders.org\/MDS\/About\/Movement-Disorder-Overviews\/Chorea--Huntingtons-Disease.htm. Accessed 9 Jul 2025"},{"key":"13703_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/B978-0-444-52014-2.00017-3","volume":"100","author":"F Grandas","year":"2011","unstructured":"Grandas F (2011) Hemiballismus. Handb Clin Neurol 100:249\u2013260","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"13703_CR16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/mds.23088","volume":"25","author":"TD Sanger","year":"2010","unstructured":"Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW et al (2010) Definition and classification of hyperkinetic movements in childhood. Mov Disord 25(11):1538\u20131549","journal-title":"Mov Disord"},{"key":"13703_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780190865047.001.0001","volume-title":"Involuntary movements [Internet]","author":"H Shibasaki","year":"2020","unstructured":"Shibasaki H, Hallett M, Bhatia KP, Reich SG, Balint B (2020) Athetosis and Dystonia. Involuntary movements [Internet]. Oxford University Press"},{"key":"13703_CR18","unstructured":"Healthline [Internet] 2018 Athetosis: definition, causes, treatment, and symptoms. Available from: https:\/\/www.healthline.com\/health\/neurological-health\/athetosis. Accessed 25 Aug 2024"},{"key":"13703_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/B978-0-407-02295-9.50018-7","volume-title":"Movement disorders [Internet]","author":"CD Marsden","year":"1981","unstructured":"Marsden CD, Hallett M, Fahn S (1981) 13\u2014The nosology and pathophysiology of myoclonus. Movement disorders [Internet]. Butterworth-Heinemann, pp 196\u2013248"},{"key":"13703_CR20","unstructured":"Myoclonus & Startle [Internet]. Available from: https:\/\/www.movementdisorders.org\/MDS\/About\/Movement-Disorder-Overviews\/Myoclonus--Startle.htm. Accessed 9 Jul 2025"},{"issue":"3","key":"13703_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4103\/aian.AIAN_1180_20","volume":"24","author":"M Chandarana","year":"2021","unstructured":"Chandarana M, Saraf U, Divya KP, Krishnan S, Kishore A (2021) Myoclonus\u2014a review. Ann Indian Acad Neurol 24(3):327\u2013338","journal-title":"Ann Indian Acad Neurol"},{"key":"13703_CR22","volume-title":"Upper motor neurone syndrome and spasticity: clinical management and neurophysiology","year":"2008","unstructured":"Barnes MP (ed) (2008) Upper motor neurone syndrome and spasticity: clinical management and neurophysiology, 2nd edn. Cambridge University Press, Cambridge","edition":"2"},{"key":"13703_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1463292\/full","author":"J Wissel","year":"2024","unstructured":"Wissel J, Hernandez FJ (2024) Changing the view on spastic movement disorder management to improve active movement competence in the upper motor neuron syndrome: a clinical perspective. Front Neurol [Internet]. https:\/\/doi.org\/10.3389\/fneur.2024.1463292\/full","journal-title":"Front Neurol [Internet]"},{"issue":"11","key":"13703_CR24","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/mds.25558","volume":"28","author":"W Ilg","year":"2013","unstructured":"Ilg W, Timmann D (2013) Gait ataxia\u2014specific cerebellar influences and their rehabilitation. Mov Disord 28(11):1566\u20131575","journal-title":"Mov Disord"},{"issue":"4","key":"13703_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/toxins13040282","volume":"13","author":"J Ganguly","year":"2021","unstructured":"Ganguly J, Kulshreshtha D, Almotiri M, Jog M (2021) Muscle tone physiology and abnormalities. Toxins 13(4):282","journal-title":"Toxins"},{"key":"13703_CR26","volume-title":"Hyperkinetic movement disorders [Internet]","author":"BL Walter","year":"2012","unstructured":"Walter BL, Vitek JL (2012) Pathophysiology of hyperkinetic movement disorders. In: Suchowersky O, Comella C (eds) Hyperkinetic movement disorders [Internet]. Humana Press, Totowa NJ"},{"key":"13703_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00012","volume":"9","author":"A Quartarone","year":"2018","unstructured":"Quartarone A, Ruge D (2018) How many types of dystonia? Pathophysiological considerations. Front Neurol 9:12","journal-title":"Front Neurol"},{"issue":"4","key":"13703_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/WCO.0000000000000829","volume":"33","author":"AM Madelein Van Der Stouwe","year":"2020","unstructured":"Madelein Van Der Stouwe AM, Nieuwhof F, Helmich RC (2020) Tremor pathophysiology: lessons from neuroimaging. Curr Opin Neurol 33(4):474\u2013481","journal-title":"Curr Opin Neurol"},{"key":"13703_CR29","first-page":"jrm00241","volume":"54","author":"B Biering-Soerensen","year":"2022","unstructured":"Biering-Soerensen B, Stevenson V, Bensmail D, Grabljevec K, Mart\u00ednez Moreno M, Pucks-Faes E et al (2022) European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and\/or botulinum toxin type A. J Rehabil Med 54:jrm00241","journal-title":"J Rehabil Med"},{"issue":"5","key":"13703_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/practneurol-2011-000155","volume":"12","author":"A Kheder","year":"2012","unstructured":"Kheder A, Nair KPS (2012) Spasticity: pathophysiology, evaluation and management. Pract Neurol 12(5):289\u2013298","journal-title":"Pract Neurol"},{"issue":"1","key":"13703_CR31","first-page":"19","volume":"12","author":"I Boyraz","year":"2015","unstructured":"Boyraz I, Uysal H, Koc B, Sarman H (2015) Clonus: definition, mechanism, treatment. Med Glas Off Publ Med Assoc Zenica-Doboj Cant Bosnia Herzeg 12(1):19\u201326","journal-title":"Med Glas Off Publ Med Assoc Zenica-Doboj Cant Bosnia Herzeg"},{"key":"13703_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/354906","volume":"2014","author":"C Trompetto","year":"2014","unstructured":"Trompetto C, Marinelli L, Mori L, Pelosin E, Curr\u00e0 A, Molfetta L et al (2014) Pathophysiology of spasticity: implications for neurorehabilitation. BioMed Res Int 2014:354906","journal-title":"BioMed Res Int"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13703-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13703-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13703-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:02:10Z","timestamp":1773784930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13703-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13703"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13703-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant conflict of interest with respect to the contents of this manuscript. BBS has received honoraria for lectures from IPSEN, Merz, Abbvie, Medtronic, Orion Pharma, Ambu, Britannia; received honoraria for participating in Advisory Boards from IPSEN, Merz, Innoventa Medica, Abbvie and TEVA; received unconditional grants and funding for Investigator-initiated clinical trials from Merz, Ortbit Health, Britannia. JW has received honoraria for lectures from AbbVie, Ipsen, and Merz; has received honoraria for participating in Advisory Boards AbbVie, Ipsen, and Merz. RR contracted researches with the Michael J. Fox Foundation Genetics of Parkinson\u2019s Disease, (GP2, monogenic and complex), with the University of Lubeck\u00a0XDP Collaboration and with the University of Santo Tomas\u00a0Research Center for Health Sciences.\u00a0He participated in the advisory board with travel and lecture honoraria for Ipsen, Abbvie, Eisai, Otsuka Viatris, and Sun pharma. RReebye has received honoraria for participating in Advisory Boards from Ipsen, Abbvie, and Merz. JJ has received honoraria for participating in Advisory boards, lecturing, sponsored clinical research and peer training for Abbvie, Ipsen, and Merz pharmaceutical companies. GEF has received research grants from Abbvie, Merz, Ottobock, Revance Therapeutics, Saol Therapeutics. Done consulting for Abbvie, Ipsen, Lifeward, Merz, Saol Therapeutics. PS has received honoraria for lectures from IPSEN, Merz, Abbvie, Medtronic, Orion Pharma, Ambu, Britannia; has received honoraria for participating in Advisory Boards from IPSEN, Merz, Abbvie; has received unconditional grants and funding for Investigator-initiated clinical trials from Merz, Ortbit Health, Britannia. PE has received honoraria for lectures and hosting advisory board for IPSEN.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"154"}}